Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Clinical trial: vitamin D3 treatment in Crohn’s disease – a randomized double‐blind placebo‐controlled study
- S. Jørgensen, J. Agnholt, +7 authors J. Dahlerup
- Medicine
- Alimentary pharmacology & therapeutics
- 1 August 2010
Aliment Pharmacol Ther 2010; 32: 377–383
East–West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort
- J. Burisch, N. Pedersen, +51 authors P. Munkholm
- Medicine
- Gut
- 20 April 2013
Objective The incidence of inflammatory bowel disease (IBD) is increasing in Eastern Europe. The reasons for these changes remain unknown. The aim of this study was to investigate whether an… Expand
The impact of M-component type and immunoglobulin concentration on the risk of malignant transformation in patients with monoclonal gammopathy of undetermined significance.
- H. Gregersen, L. Mellemkjaer, J. Ibsen, J. Dahlerup, L. Thomassen, H. Sørensen
- Medicine
- Haematologica
- 2001
BACKGROUND AND OBJECTIVES
In this study the impact of gender, age, type of M-component and concentration of immunoglobulins on the risk of malignant transformation in monoclonal gammopathy of… Expand
Bile acid malabsorption investigated by selenium-75-homocholic acid taurine ((75)SeHCAT) scans: causes and treatment responses to cholestyramine in 298 patients with chronic watery diarrhoea.
- M. Borghede, J. Schlütter, J. Agnholt, L. A. Christensen, L. Gormsen, J. Dahlerup
- Medicine
- European journal of internal medicine
- 1 December 2011
BACKGROUND
The liver produces and secretes bile acids into the small intestine. In the small intestine, most of the bile acids are absorbed in the distal ileum with portal vein transportation back to… Expand
The mucosal addressin cell adhesion molecule antibody PF-00547,659 in ulcerative colitis: a randomised study
- S. Vermeire, S. Ghosh, +8 authors W. Niezychowski
- Medicine
- Gut
- 11 February 2011
Background and aims Leucocyte migration to gut mucosa, mediated by integrin binding to mucosal addressin cell adhesion molecule (MAdCAM), is a promising target for therapeutic intervention in… Expand
1,25-dihydroxyvitamin D3 and dexamethasone increase interleukin-10 production in CD4+ T cells from patients with Crohn's disease.
- L. E. Bartels, S. Jørgensen, J. Agnholt, J. Kelsen, C. Hvas, J. Dahlerup
- Medicine
- International immunopharmacology
- 15 December 2007
BACKGROUND AND AIM
In Crohn's disease (CD), epidemiological data and animal studies suggest that vitamin D (vitD) has protective immune-modulating properties. 1,25-dihydroxyvitamin D3 and… Expand
Fatigue in out‐patients with inflammatory bowel disease is common and multifactorial
- P. Bager, R. Befrits, +5 authors J. Dahlerup
- Medicine
- Alimentary pharmacology & therapeutics
- 1 January 2012
Aliment Pharmacol Ther 2012; 35: 133–141
Drug‐specific hypophosphatemia and hypersensitivity reactions following different intravenous iron infusions
- P. Bager, C. Hvas, J. Dahlerup
- Medicine
- British journal of clinical pharmacology
- 1 May 2017
Aims Intravenous (IV) iron infusions have been associated with hypophosphataemia (HP) and hypersensitivity reactions (HSRs). No studies have compared the side effects of ferric carboxymaltose (FCM)… Expand
Guidelines for screening, prophylaxis and critical information prior to initiating anti-TNF-alpha treatment.
- Inge Nordgaard-Lassen, J. Dahlerup, +7 authors L. Tjellesen
- Medicine
- Danish medical journal
- 1 July 2012
These national clinical guidelines outlining the screening, prophylaxis and critical information required prior to initiating anti-TNF-alpha treatment have been approved by the Danish Society for… Expand
Vitamin D3 treatment of Crohn’s disease patients increases stimulated T cell IL‐6 production and proliferation
- M. Bendix-Struve, L. E. Bartels, J. Agnholt, A. Dige, S. Jørgensen, J. Dahlerup
- Medicine
- Alimentary pharmacology & therapeutics
- 1 December 2010
Aliment Pharmacol Ther 2010; 32: 1364–1372